(Reuters) - Celgene Corp said the U.S. Food and Drugs Administration has approved the expanded use of its drug Otezla for treating patients with... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/XGpgYObsGUM/us-celgene-fda-approval-idINKCN0HI2DR20140923
From the Wires Proceeds to drive manufacturing, sales and marketing programs for LabStyle's Dario in Europe and elsewhere, as well as ongoing FDA... ...http://in.sys-con.com/node/3196220
MARLBOROUGH, Mass. , Sept. 23, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical trial, a... ...http://in.advfn.com/p.php?pid=nmona&article=63783328
Seattle Children's Research Institute Awarded $1.6 Million to Lead National Study on Heart Defects The U.S. Food and Drug Administration's Office... ...http://health.infrosoft.com/index.php?page=news&op=readNews&id=44212&title=Seattle-Childrens-Research-Institute-Awarded-%241-6-Million-to-Lead-National-Study-on-Heart-Defects
From the Wires Wisconsin Families & Farmers Benefit From Support Sep. 23, 2014 01:03 PM WASHINGTON , Sept. 23, 2014... ...http://in.sys-con.com/node/3195966
An additional reason precisely why...